Abstract Details

Title Frovatriptan for the Prevention of Menstrual Migraine Headaches: Results of a 12-Month Open-Label Safety and Tolerability Study

Topic Headache and Pain

Presentation(s) (-)

Poster/Presentation
Number 097

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rodney Christensen (Kansas City Kansas Community College)	No disclosure on file
John Tobin	No disclosure on file
	No disclosure on file
Barry Byrne	Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
John Campbell	No disclosure on file

��ɫ��